Training Course on WHO Classification: Towards Personalized Medicine in Haematology

Training Course on WHO Classification:
Towards Personalized Medicine in Haematology
Chairs: Matteo G. Della Porta, Torsten Haferlach, Andreas Hochhaus,
Eva Hellström-Lindberg, Mario Cazzola
Dates: March 9-11, 2017
Venue: Saggart (Dublin), Ireland

Programme description:
The WHO classification of tumours of haematopoietic and lymphoid tissues aims to establish a pathological and genetic classification of haematological malignancies that is accepted and used worldwide, as a basis for diagnostic work-up, clinical decision making process and clinical trials.

In recent years, the availability of new technologies for genomic analysis (next-generation sequencing, NGS) has enabled the high-throughput screening of somatic mutations in haematological malignancies. It is expected that the results of these studies will significantly improve the management of individual patients through the implementation of innovative diagnostic/prognostic systems and the development of therapeutic strategies based on individual genomic profile.

As a result of recent advances in the understanding of the molecular architecture of haematological malignancies, the 2016 update of the WHO classification includes an increasing amount of new, clinically relevant genomic information and will represent a solid basis for the implementation of personalized (precision) medicine programmes.

In the definition of personalized (precision) medicine, the word personalized conveys the sense that cancer genomic data may facilitate diagnosis and rational treatment choices that are tailored to individual patients, while the term precision refers to prospects for enhanced molecular resolution, mechanistic clarity, and therapeutic cogency that may accompany clinical implementation of genomics technologies.

Conceptually, the implementation of personalized medicine in haematology might seem straightforward: first, characterize the genomes of patients’ tumours using NGS technologies; second, filter the genomic data through a knowledge base of existing and emerging anticancer drugs; and finaly, present an annotated list to haematologists that can be incorporated into clinical decision making.

However, multiple challenges must be addressed to bring this ambitious goal to fruition. To begin with, high-quality genomic information must be obtained consistently in the diagnostic setting. The spread of massive genotyping methods will soon make it possible for clinicians to detect a broad range of mutations in peripheral blood at a reasonable cost. This will facilitate the diagnosis/treatment choice in patients with haematological malignancies. The analytic challenges that accompany comprehensive genomic data have proven more problematic: the somatic alterations that are relevant to each cancer (driver mutations) must be identified with high accuracy, and must be distinguished from the much larger set of passenger alterations that are present in tumour DNA. Rigorous analysis and correct clinical interpretation of comprehensive genomic data is impossible without the assistance of computational algorithms to support clinical-grade data interpretation. Finally, haematologists must forge a cohesive framework whereby genomic information propels a new generation of evidence-based clinical trials.

Educational objectives:
Specific aims are:

a) To provide ABCs of genomics for clinicians

b) To provide information on recent advances in the understanding of the genome of haematological malignancies

c) To provide examples of the integration of somatic mutations into diagnosis and clinical decision-making in haematology.

The program will include:

– Plenary Sessions
– Simultaneous Meet the Experts Sessions
– Round Table Discussions
– Poster Presentations

PLEASE FIRST REGISTER FOR THE CONFERENCE BEFORE SUBMITTING AN ABSTRACT

EXTENDED DEADLINE FOR SUBMISSION OF ABSTRACTS: FEBRUARY 8th, 2017

Submit your abstract(s) on-line:

https://esh.confex.com/esh/who/gs/papers/index.cgi
 

Please find below the abstract guidelines:

• Your abstract can be structured (eg Objectives, Methods, Results, Conclusions) or unstructured.
• Maximum number of words: 400
• You abstract will be submitted to the peer review procedure. 

The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).

Check that you do receive an acknowledgement of your submitted abstract. If not, contact Emilie Letertre.

IN ORDER TO BENEFIT FROM SPECIAL CONFERENCE RATES PLEASE BOOK YOUR HOTEL
ACCOMMODATION THROUGH THE HOTEL WEBSITE AFTER REGISTRATION:

CityWest Hotel
Saggart, Co Dublin
IRELAND

www.citywesthotel.com
Please insert the Promotional Code: ESH2016

CityWest Hotel
Saggart, Co Dublin
IRELAND

The CityWest Hotel is located in Saggart just a 20 minute drive from Dublin International Airport.
It offers excellent conference facilities as well as onsite hotel accommodation.

The registration fee for the Training Course on WHO Classification: Towards Personalized Medicine in Haematology
600€ (fully trained)
300€ (in training: a proof will be requested to confirm your status)

This fee includes:
Your seat in the conference
The conference materials,
Welcome cocktail, luncheons and refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

 
Type of payment :

 
A) By Cheque :

ESH, Centre Hayem, Hôpital Saint Louis
1 Avenue Claude Vellefaux
75475 Paris Cedex 10
France

 
B) By Bank transfer :

NAME : ESH
RIB :     30004      01730     00010099772     92 
IBAN code : FR76 3000 4017 3000 0100 9977 292
BIC code : BNPAFRPPPBU

 
C) By Credit card : VISA, MASTERCARD, AMEX

 
Cancellation policy of registration fee :

In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges).
If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges).
Cancellations notified 15 days before the meeting will not be reimbursed.

 
How to proceed :

Please make sure that your Internet browser (Firefox, Internet Explorer, Safari, Google Chrome…) is up-to-date. Using an old version may prevent you from visualising the full website content.

A) For Individual Registration:
1. Register yourself on the ESH Virtual Network using your personal data.
2. Please go to the registration page of the conference you would like to attend.
3. Click on the INDIVIDUAL REGISTRATION button to complete your registration.
4. Proceed with the payment.

B) For Third Party Registration:
1. Create a Virtual Network profile for the person who will participate in the event (It is very important to provide the personal email address corresponding to the participant. Your details can be added to the « Address of Invoicing » section.)
2. You and the third party will receive a confirmation email with the username (email address of the third party) and password détails (please note the password that you use to open the Virtual Network account).
3. Return to the registration page of the conference the third party would like to attend.
4. Click on the INDIVIDUAL REGISTRATION button to complete the third party registration and proceed with payment.

C) For Group Registration (More than one person):
1. Create your Virtual Network profile using your personal data.
2. You will receive a confirmation email with your username and password details.
3. Return to the registration page of the conference in which you would like to register your group.
4. Click on the GROUP REGISTRATION button to fill in the complete details for each person that you would like to register (Use the personal email address of each participant you are registering, failure to do so will prohibit you from completing the registrations.)

Register Here